e-learning
resources
Munich 2014
Monday, 08.09.2014
Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Concomitant latent tuberculosis in patients with lung cancer
W. J. Su, W. C. Fan, J. Y. Feng, S. F. Huang (Taipei, Miaoli, Taiwan)
Source:
International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Session:
Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Session type:
Thematic Poster Session
Number:
2627
Disease area:
Respiratory infections, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. J. Su, W. C. Fan, J. Y. Feng, S. F. Huang (Taipei, Miaoli, Taiwan). Concomitant latent tuberculosis in patients with lung cancer. Eur Respir J 2014; 44: Suppl. 58, 2627
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Lung cancer and lung tuberculosis: Our results of treatment in the combined lung disease
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016
Pulmonary tuberculosis and lung cancer: A complex interaction
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016
Confirmed pulmonary tuberculosis leading to late diagnosis of lung cancer - Study case
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013
The association of lung cancer with active pulmonary tuberculosis.
Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases
Year: 2014
Active TB in cancer patients: A missed screening opportunity?
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Latent tuberculosis infection and the risk of cancer: A nationwide population-based study
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015
Miliary disease of the lung: What is your diagnosis?
Source: Annual Congress 2013 –Morphologic imaging
Year: 2013
Prevalence of COPD and emphysema at the time of diagnosis of primary lung cancer
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
The value of immunological methods in the diagnosis of tuberculosis in patients with HIV
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Evaluation of predictive and therapeutic value of WSX1/IL27 axis in non-small cell lung cancer (NSCLC)
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
CD8-response associates with active tuberculosis and TB2-tube response in the QuantiFERON-TB-Plus kit
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016
Lung function in the elderly patients with a diagnosis of lung cancer - A challenge for the surgical treatment?
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015
Treatment for latent tuberculosis infection in migrants carries a low risk of hepatotoxicity
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
Lung diseases infection and risk of lung cancer
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Prevalence of preinvasive bronchial lesions in patients with lung cancer
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013
Prognostic factors affecting survival in cases with lung cancer [A lung cancer mapping project in Turkey (LCMPT)]
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
The impact of HIV infection on the presentation and prognosis of lung cancer
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016
Evaluation of incidental lung cancer in hospitalized patients with non-respiratory disease
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016
Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
A rare diagnosis after pediatric tuberculosis screening
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept